Literature DB >> 7483763

Immune response of calves to foot-and-mouth disease virus vaccine emulsified with oil adjuvant. Strategies of vaccination.

E J Späth1, E Smitsaart, A P Casaro, N Fondevila, F Fernández, M R Leunda, D Compaired, M Buffarini, H Pessi.   

Abstract

Calves born to vaccinated cows under the regular annual vaccination programme were vaccinated at different ages using commercial quadrivalent (01, A79, A87 and C85 FMDV strains) vaccine emulsified in oil adjuvant. The antibody responses of vaccinated calves were evaluated using liquid-phase blocking sandwich ELISA. All calves 20, 30 and 40 days old having high maternal antibody titres responded well to vaccination. Moreover, 25-57% of vaccinated calves showed protective antibody titres both at 90 and 120 days post-vaccination (d.p.v.), whereas none of the non-vaccinated animals achieved these levels. Calves aged 3-4 months with non-protective levels of colostral-derived antibodies responded with high antibody titres to vaccination which persisted for at least 4 months. In both groups of calves a certain degree of suppression of postvaccinal response was observed which was related to colostral antibody titres. Our results suggest that in order to reduce the proportion of calves susceptible to infection it is advisable to immunize calves as young as 20 days old to induce acceptable antibody titres for the following 4 months. In addition, a second vaccination 60 d.p.v. ensures high antibody levels in high disease risk areas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483763     DOI: 10.1016/0264-410x(95)00009-p

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Intratypic heterologous vaccination of calves can induce an antibody response in presence of maternal antibodies against foot-and-mouth disease virus.

Authors:  Aldo Dekker; Phaedra Eblé; Norbert Stockhofe; Gilles Chénard
Journal:  BMC Vet Res       Date:  2014-06-06       Impact factor: 2.741

2.  QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle.

Authors:  Can Çokçalışkan; Tunçer Türkoğlu; Beyhan Sareyyüpoğlu; Ergün Uzunlu; Ayca Babak; Banu B Özbilge; Veli Gülyaz
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

3.  Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattle.

Authors:  T J D Knight-Jones; S Gubbins; A N Bulut; K D C Stärk; D U Pfeiffer; K J Sumption; D J Paton
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

4.  Immunogenicity of imported foot-and-mouth vaccines in different species in Mongolia.

Authors:  Gerelmaa Ulziibat; Odonchimeg Maygmarsuren; Bodisaikhan Khishgee; Ganzorig Basan; Batkhuyag Sandag; Sodnomdarjaa Ruuragc; Georgina Limon; Ginette Wilsden; Clare Browning; Donald P King; Anna B Ludi; Nicholas A Lyons
Journal:  Vaccine       Date:  2020-01-09       Impact factor: 3.641

5.  Requirements for improved vaccines against foot-and-mouth disease epidemics.

Authors:  Jong-Hyeon Park
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15

6.  Influence of vaccine potency and booster administration of foot-and-mouth disease vaccines on the antibody response in calves with maternal antibodies.

Authors:  Can Çokçalışkan; Tunçer Türkoğlu; Ergün Uzunlu; Beyhan Sareyyüpoğlu; İbrahim Hancı; Ahmet İpek; Abdullah Arslan; Ayca Babak; Gülnur İldeniz; Veli Gülyaz
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.